Jimmy Hwang, MD, discusses currently available first-line treatment options in hepatocellular carcinoma, and areas of continued unmet need in this space.
Jimmy Hwang, MD
Advertisement
Articles by Jimmy Hwang, MD
Jimmy Hwang, MD, discusses considerations for second-line treatment in gastric/gastroesophageal junction cancer.
Advertisement
Latest Updated Articles
Dr. Hwang on Considerations for Second-Line Treatment in Gastric/GEJ CancerPublished: July 1st 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5